Group One Trading’s Aptose Biosciences, Inc. APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6
Closed -$4K 9001
2021
Q4
$4K Sell
6
-2
-25% -$1.88K ﹤0.01% 7746
2021
Q3
$7K Sell
8
-35
-81% -$43.8K ﹤0.01% 7661
2021
Q2
$64K Sell
43
-35
-45% -$76.2K ﹤0.01% 6369
2021
Q1
$210K Buy
78
+57
+271% +$113K ﹤0.01% 4979
2020
Q4
$42K Buy
21
+20
+2,000% +$47K ﹤0.01% 5129
2020
Q3
$2K Sell
1
-7
-88% -$17.5K ﹤0.01% 5864
2020
Q2
$23K Sell
8
-19
-70% -$61.3K ﹤0.01% 4773
2020
Q1
$73K Buy
+27
New +$80.5K ﹤0.01% 3506
2019
Q4
Sell
-11
Closed -$10K 5785
2019
Q3
$10K Buy
+11
New +$12.5K ﹤0.01% 4608

Other funds holding APTO

Group One Trading's APTO Position: Q2 2025 in Review

Group One Trading sold out of Aptose Biosciences, Inc. (APTO) in Q2 2025, closing a stake of 3 shares — an estimated $9 sold.

Group One Trading first reported a position in APTO in Q3 2019 and held it in 19 quarters. The position peaked at $508K in Q2 2021. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.

  • Group One Trading reported no remaining Aptose Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 3 Aptose Biosciences, Inc. shares in Q2 2025, an estimated $9.
  • Group One Trading first reported a position in Aptose Biosciences, Inc. in Q3 2019 and held it in 19 quarters.
  • Group One Trading's Aptose Biosciences, Inc. position peaked at $508K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.